definiens: means any product comprising a peptide that block s, inhibits, or neutralizes an interleukin-23 receptor and ( i ) h as an IC50 value of less than or equal to [ * ] nanomolar, as determined in the [ * ] described in Exhibit C or ( ii ) has an affinity for IL23R less than or equal to [ * ] pM, as determined by the [ * ] described in Exhibit C ; ( b ) means any chronic intestinal disease that is char acterized by inflammation of the bowel, including UC and CD ; and ( c ) means, with respect to an activity, to use reason able, good faith efforts to segregate such activity from the Development, Ma nufacturing and Commercialization of Licensed Compounds and Licensed Products under this Agreement, including using such efforts to ensure that : ( i ) no personnel involved i n performing such activity on behalf of the Acquirer have access to non - public plans or informa tion relating to the Development, Manufacturing and Commercialization of Licensed Com pounds and Licensed Products under this Agreement ; and ( ii ) no personnel involved in p erforming the Development, Manufacturing and Commercialization of Licensed Compounds and Lic ensed Products under this Agreement have access to non - public plans or information rela ting to such activity of the Acquirer